Loading MCK detail
Loading ticker data...
Loading MCK detail
McKesson Corporation provides healthcare services in the United States and internationally.
It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Chart data unavailable
The latest trading day saw McKesson (MCK) settling at $871.18, representing a +1.7% change from its previous close.
McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Florida Trust Wealth Management Co cut its stake in shares of McKesson Corporation (NYSE: MCK) by 1.9% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 36,352 shares of the company's stock after selling 715 shares during the period. Florida Trust
In the closing of the recent trading day, McKesson (MCK) stood at $884.28, denoting a +1.37% move from the preceding trading day.
Blue Trust Inc. lessened its holdings in McKesson Corporation (NYSE: MCK) by 11.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 5,213 shares of the company's stock after selling 645 shares during the quarter. Blue Trust Inc.'s holdings in McKesson
McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Burns Matteson Capital Management LLC acquired a new stake in shares of McKesson Corporation (NYSE: MCK) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 701 shares of the company's stock, valued at approximately $575,000. Other hedge funds have also
Exchange Traded Concepts LLC lowered its position in shares of McKesson Corporation (NYSE: MCK) by 19.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,101 shares of the company's stock after selling 755 shares during the quarter. Exchange Traded Concepts LLC's holdings
Allspring Global Investments Holdings LLC increased its position in McKesson Corporation (NYSE: MCK) by 30.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 199,356 shares of the company's stock after purchasing an additional 46,799 shares during the quarter. Allspring
Barlow Wealth Partners LLC increased its stake in shares of McKesson Corporation (NYSE: MCK) by 7.8% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,123 shares of the company's stock after acquiring an additional 1,236 shares during
Czech National Bank boosted its position in shares of McKesson Corporation (NYSE: MCK) by 3.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 32,546 shares of the company's stock after acquiring an additional 955 shares during the period. Czech
CAH's turnaround gains traction with strong earnings growth and margin expansion, outpacing MCK's steady performance outlook.
McKesson Corporation (NYSE: MCK - Get Free Report) has been given a consensus rating of "Moderate Buy" by the seventeen ratings firms that are currently covering the company, Marketbeat reports. Four research analysts have rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 1 year target
McKesson's strong oncology, GLP-1, and biopharma growth fuel earnings momentum, but margin pressure and segment volatility remain key watch points.
CGN Advisors LLC decreased its holdings in shares of McKesson Corporation (NYSE: MCK) by 13.2% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,167 shares of the company's stock after selling 632 shares during the period. CGN
